Inventor · disambiguated record
Manuel Serrano Marugan
Also filed as: SERRANO MARUGAN MANUEL · SERRANO MARUGÁN MANUEL
2 granted patents·4 pending applications·0 citations·filing 2011–2024
26Inventor score
Files withFUND CENTRE DE REGULACIO GENÒMICA1FUND CENTRE DE REGULACIO GENÒMMICA1FUNDACION DEL SECTOR PUBLICO ESTATAL CENTRO NAC DE INVESTIGACIONES ONCOLOGICAS CARLOS III F S1FUNDACION DEL SECTOR PUEBLICO ESTATAL CENTRO NAC DE INVESTIGACIONES ONCOLOGICAS CARLOS II1REJUVERON SENESCENCE THERAPEUTICS AG1
Top patents by PatentIndex Score
6 records- 0160US2024344128A1Identification and elimination of damaged and/or senescent cellsFUNDACION DEL SECTOR PUEBLICO ESTATAL CENTRO NAC DE INVESTIGACIONES ONCOLOGICAS CARLOS II·Filed 2024·Application pending·0 cites
- 0249US2023414649A1Antisense oligonucleotides and uses thereofFUND CENTRE DE REGULACIO GENÒMMICA·Filed 2023·Application pending·0 cites
- 0347US11672816B2Antisense oligonucleotides and uses thereofFUND CENTRE DE REGULACIO GENÒMICA·Filed 2019·Granted Jun 13, 2023·0 cites·18 claims
- 0444US2025179187A1Anti pd-l2 antibodyREJUVERON SENESCENCE THERAPEUTICS AG·Filed 2023·Application pending·0 cites
- 0540US2020123607A1Identification and elimination of damaged and/or senescent cellsFUNDACION DEL SECTOR PUBLICO ESTATAL CENTRO NAC DE INVESTIGACIONES ONCOLOGICAS CARLOS III F S·Filed 2018·Application pending·0 cites
- 0638US9993554B2Use of P13K Inhibitors for the Treatment of Obesity, Steatosis and ageingSERRANO MARUGAN MANUEL·Filed 2011·Granted Jun 12, 2018·0 cites·12 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →